The goal was not more low-intent form fills. It was more search-driven actions with a stronger path to qualified pipeline and revenue.
The challenge Before DataXGrowth, the medical device QMS platform could not reliably scale Google Ads performance. Paid Search generated activity, but the account was not structured around the conversions most likely to become marketing-qualified leads and commercial opportunities. Scaling spend without a clear MQL and revenue-goal framework risked creating more volume without improving pipeline quality.
The DataXGrowth approach DataXGrowth restructured Paid Search around intent, MQL-quality, and revenue-driving goal conversions rather than optimizing toward low-value actions alone. The work focused on identifying the search campaigns, keywords, and conversion actions most likely to produce qualified demand; aligning bidding and budget decisions to those signals; and scaling the areas of the account that demonstrated stronger commercial value. This created a clearer connection between Paid Search investment, qualified lead actions, and the sales outcomes the business needed to grow.
The results From December 17, 2025 through February 28, 2026, Paid Search produced 40.08 tracked goal conversions at a cost per conversion of $343.71. From March 1 through September 18, 2026, Paid Search produced 528.60 tracked goal conversions at a cost per conversion of $309.19. That increased daily tracked goal conversions from 0.54 to 2.62 — a 4.8× increase — while reducing cost per conversion by 10%. The program generated 488.52 additional tracked goal conversions after the Paid Search restructure.